SCHEMBL2994971

SCHEMBL2994971

O=C(O)Cc1ccc(Oc2ccc(NC(=O)c3ccccc3)cc2)c(CNS(=O)(=O)c2ccc(F)cc2)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.49
MEN1 O00255 5/20 0.49
ALDH1A1 P00352 3/20 0.49
KDM4E B2RXH2 2/20 0.49
GPR55 Q9Y2T6 1/20 0.49
TDP1 Q9NUW8 1/20 0.48
HTT P42858 1/20 0.47
LMNA P02545 3/20 0.47
CXCR4 P61073 1/20 0.46
MAPT P10636 2/20 0.45
GAA P10253 1/20 0.45
RECQL P46063 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
HPGD P15428 1/20 0.45
RAB9A P51151 2/20 0.44
SGMS1 Q86VZ5 1/20 0.44
NPC1 O15118 1/20 0.44
USP30 Q70CQ3 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2989885 0.92 ENPP1 (0.52) KMT2AMEN1ALDH1A1KDM4EGPR55
SCHEMBL2987524 0.92 GPR17 (0.51) KMT2AMEN1ALDH1A1KDM4EHTT
SCHEMBL2991909 0.89 KDM4E (0.52) KMT2AMEN1KDM4EGPR55TDP1
SCHEMBL6755943 0.87 PGR (0.47) KMT2AMEN1RAB9ANPC1
SCHEMBL2987825 0.82 NAMPT (0.47) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL2975299 0.81 MEN1 (0.47) KMT2AMEN1ALDH1A1KDM4ETDP1
SCHEMBL2984379 0.78 SLC6A2 (0.48) KDM4EMAPTRECQL
SCHEMBL2988699 0.78 NR1H4 (0.52) KMT2AMEN1TDP1MAPTRAB9A
SCHEMBL2990485 0.78 SLC6A2 (0.42) KMT2AMEN1KDM4ELMNAMAPT
SCHEMBL2977839 0.77 MEN1 (0.55) KMT2AMEN1ALDH1A1KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2012-08-09 US claimed
US-8492437-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2013-07-23 US disclosed
US-8492437-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2013-07-23 US disclosed
EP-2057115-B9 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2012-12-26 EP disclosed
EP-2057115-B1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2012-10-03 EP disclosed
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2012-08-09 US disclosed
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2012-08-09 US disclosed
US-8183289-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2012-05-22 US disclosed
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2010-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 KMT2A 505/4885MEN1 4149/4885ALDH1A1 610/4885
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 KMT2A 505/4885MEN1 4149/4885ALDH1A1 610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.